Korean J Psychopharmacol.  2006 Mar;17(2):238-240.

Vaginal Bleeding Associated with Venlafaxine Add-On Therapy: A Case Report

• Jon DI

Abstract

Venlafaxine is often considered to be safer than established antidepressants except the risk of hypertension. In terms of vaginal bleeding associated with venlafaxine, only one case has been reported. The author describes a vaginal bleeding occurred in a 38-year-old depressed patient who has been receiving additional venlafaxine during fluoxetine medication. Discontinuation of venlafaxine supported the assumption that the vaginal bleeding was an adverse drug reaction of venlafaxine. Physicians should be alerted to the possibility of bleeding tendency in patients who have taken venlafaxine.

Keyword

Venlafaxine; Vaginal bleeding; Add-on therapy; Fluoxetine

MeSH Terms

Adult
Antidepressive Agents
Drug-Related Side Effects and Adverse Reactions
Fluoxetine
Hemorrhage
Humans
Hypertension
Uterine Hemorrhage*
Venlafaxine Hydrochloride
Antidepressive Agents
Fluoxetine